For Medical Professionals
Visiter betcliccasinos.org régulièrement permet de mesurer la fréquence des mises à jour et la vitalité du catalogue. Les amateurs de jeux Drop & Win bénéficient d’une rotation hebdomadaire des tournois associés. Les sessions interrompues par un changement de réseau reprennent automatiquement à leur point d’arrêt. Apple Pay et Google Pay sont reconnus comme moyens de paiement principaux pour les usages mobiles. Le cashback VIP atteint parfois des pourcentages bien supérieurs aux paliers standards. Les outils de jeu responsable comprennent l’auto-exclusion, les limites de dépôt et les rappels temporels. Les casinos virtuels en environnement 3D commencent à apparaître progressivement dans le catalogue live. Les notices explicatives détaillent les conditions de chaque promotion en cours. Les fonctionnalités d’analyse personnelle aident à comprendre ses propres habitudes de jeu. Le mode sombre s’active d’un seul clic et s’adapte automatiquement aux préférences système. Au bout du parcours, l’impression globale demeure clairement positive et invite à la fidélité.
SJS Fact Sheet
Ophthalmologic management
Very important vision-saving treatment: The Ophthalmologic Management of Acute Stevens-Johnson Syndrome, by Darren G. Gregory, MD. To view the full article, please [click here]
IVIG treatment
If started in the acute stage of SJS, IVIG (immunoglobulin treatment) has been successful in treating some SJS patients. It has shortened the course and limited side effects. Read about IVIG Treatment
Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
http://www.ncbi.nlm.nih.gov/pubmed/19775409
Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis over a Period of 10 Years in Vajira Hospital, Navamindradhiraj University, Bangkok
http://www.hindawi.com/journals/drp/2014/237821/
Stevens-Johnson Syndrome & Toxic Epidermal Necrolysis
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are now considered variants of the same condition, distinct from erythema multiforme. SJS/TEN is a very rare, acute, serious, and potentially fatal skin reaction in which there is sheet-like skin and mucosal loss. Using current definitions, it is usually, possibly always, caused by medications.
Full article on SJS/TEN. DermNet NZ
Toxic epidermal necrolysis and Stevens-Johnson syndrome
Thomas Harr* and Lars E French http://www.ojrd.com/content/5/1/39
Prevention of Vulvovaginal Sequelae in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218548/
Recurrence and outcomes of Stevens – Johnson Syndrome and Toxic Epidermal Necrolysis in Children. Click here: http://pediatrics.aappublications.org/content/early/2011/08/30/peds.2010-3322.full.pdf
Products designed by healthcare professionals
Solace Nutrition is a medical nutrition company founded with the intent to develop clinical nutrition products designed for individuals living with chronic disease. Solace Nutrition is dedicated to providing products that meet the nutritional needs that change throughout the lifecycle of individuals living with a chronic disease.
Brandeis studies evaluate a visionary approach to improving eyesight
A novel scleral lens developed in Boston has proven clinically beneficial in patients who have failed conventional therapies. To view the full article, please: [click here].
Burn unit treatment of three Stevens-Johnson Syndrome cases with Cryopreserved Allograft
Three cases of Stevens-Johnson syndrome are described. This syndrome is characterized by extensive loss of tffe epidermis and other complications. The cutaneous lesions are similar to second-degree burns in their development, and they benefit from temporary coverage with cryopreserved allografts, as may be performed in a Burns Centre: [click here].
Chronic lung disease following Stevens – Johnson Syndrome:
http://www.indianpediatrics.net
Stem cell transplantation of ocular surface diseases